Authors

L. H. Kapur; Y. Khaled; M. Solh; D. Ward;C. C. Chang

Comments

Authors: contact us about adding a copy of your work at [email protected]

Abbreviated Journal Title

Arch. Pathol. Lab. Med.

Keywords

OF-THE-LITERATURE; LEUKEMIA; DISEASE; Medical Laboratory Technology; Medicine, Research & Experimental; Pathology

Abstract

Hepatosplenic T-cell lymphoma is a rare and aggressive peripheral T-cell malignancy that is distinctively characterized by sinusoidal infiltration of mature medium-sized T lymphocytes in the spleen and liver. The neoplastic cells are classically surface CD3(+), CD2(+), CD5(-), CD4(-), and CD8(+/-) and manifest variable expression of markers associated with natural killer (NK) cells such as CD16 and CD56. In this article, we report the first case to date of a newly diagnosed de novo surface CD3(-) hepatosplenic T-cell lymphoma with circulating blastlike neoplastic cells expressing NK-cell-associated markers. The lack of surface CD3 expression, together with the expression of NK-cell-associated markers and the leukemic presentation, leads to significant diagnostic challenges in differentiating this CD3(-) hepatosplenic T-cell lymphoma from NK-cell neoplasms, in particular aggressive NK-cell leukemia. The related literature is reviewed, and the approaches for adequate diagnosis of this novel situation are described.

Journal Title

Archives of Pathology & Laboratory Medicine

Volume

138

Issue/Number

7

Publication Date

1-1-2014

Document Type

Article

Language

English

First Page

969

Last Page

973

WOS Identifier

WOS:000339593100022

ISSN

0003-9985

Share

COinS
 

Accessibility Statement

This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.